beta-lapachone has been researched along with Anemia in 1 studies
beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase
beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noh, JY | 1 |
| Park, JS | 1 |
| Lim, KM | 1 |
| Kim, K | 1 |
| Bae, ON | 1 |
| Chung, SM | 1 |
| Shin, S | 1 |
| Chung, JH | 1 |
1 other study available for beta-lapachone and Anemia
| Article | Year |
|---|---|
A naphthoquinone derivative can induce anemia through phosphatidylserine exposure-mediated erythrophagocytosis.
Topics: Adenosine Triphosphate; Adolescent; Adult; Anemia; Animals; Calcium; Erythrocyte Membrane; Erythrocy | 2010 |